Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Third Rock Ventures IV, L.P. files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Harold Bernstein - $6.05M of MAZE open-market activity in the last 12 months
- Adam Crystal - $5.72M of TNGX open-market activity in the last 12 months
- Jason V. Coloma - $3.75M of MAZE open-market activity in the last 12 months
- Atul Dandekar - $1.70M of MAZE open-market activity in the last 12 months
- Catherine A. Sohn - $1.15M of MAZE open-market activity in the last 12 months
- Amy Bachrodt - $757K of MAZE open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
What is Third Rock Ventures IV, L.P.?
Third Rock Ventures IV, L.P. is an investment firm of Maze Therapeutics, Inc. (MAZE). InsiderAlpha holds 7 primary Form 4 filings for it, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Third Rock Ventures IV, L.P. last file a Form 4?
The most recent primary Form 4 on record is dated 5 November 2025, one of 7 filings going back to 2025.
Has Third Rock Ventures IV, L.P. been buying or selling stock?
Recorded transactions: 0 open-market purchases and 7 open-market sales ($26.35M) across all tracked filings.
Where can I see all of Third Rock Ventures IV, L.P.'s SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Third Rock Ventures IV, L.P. and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
